New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks

Objective To evaluate prevalence and risk factors of moderate-severe Bronchopulmonary dysplasia (BPD)/Death in extremely low gestation age neonates (ELGANs). Study design Study of 266 ELGANs born at gestational age (GA) ≤ 28 weeks (w). Primary Outcome measure—composite outcome of moderate-severe BPD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of perinatology 2021-08, Vol.41 (8), p.1943-1950
Hauptverfasser: Geetha, Odattil, Rajadurai, Victor Samuel, Anand, Amudha Jayanthi, Dela Puerta, Rowena, Huey Quek, Bin, Khoo, Poh Choo, Chua, Mei Chien, Agarwal, Pratibha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To evaluate prevalence and risk factors of moderate-severe Bronchopulmonary dysplasia (BPD)/Death in extremely low gestation age neonates (ELGANs). Study design Study of 266 ELGANs born at gestational age (GA) ≤ 28 weeks (w). Primary Outcome measure—composite outcome of moderate-severe BPD/Death using the National Institute of Child Health and Human Development NICHD’s (2001) BPD definition. Result Cohort’s mean GA and birth-weight (BW) were 25.3 ± 1.4w and 724 ± 14 g respectively with an overall mortality of 19% and moderate-severe BPD of 67%. Prevalence of moderate-severe BPD/death decreased significantly with increasing GA (86–93%) at 23–24 w; to 25%(OR 1.06; 95% CI; 1.01–1.11); and mechanical ventilation(MV) on Day7 (OR5.5; 95% CI; 2.8–10.8). Only need for Day7 MV was independently predictive of composite outcome (OR1.97; 95% CI; 1.3–3.1). Conclusion Risk factor identification will enable initiatives to implement lung protective strategies and develop prospective models for BPD prediction and prognostication.
ISSN:0743-8346
1476-5543
DOI:10.1038/s41372-021-01095-6